Allarity Therapeutics Inc. (NASDAQ: ALLR)
$0.20
+0.0040 ( +2.04% ) 3.0M
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Market Data
Open
$0.20
Previous close
$0.20
Volume
3.0M
Market cap
$5.09M
Day range
$0.18 - $0.20
52 week range
$0.18 - $69.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Jul 01, 2024 |
def | Proxies and info statements | 4 | Jul 01, 2024 |
8-k | 8K-related | 15 | Jun 28, 2024 |
8-k | 8K-related | 15 | Jun 26, 2024 |
pre | Proxies and info statements | 4 | Jun 21, 2024 |
8-k | 8K-related | 13 | Jun 21, 2024 |
8-k | 8K-related | 14 | Jun 06, 2024 |
8-k/a | 8K-related | 13 | May 24, 2024 |
8-k | 8K-related | 16 | May 21, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |